The state of the art in dual-acting hybrid antibiotics to combat bacterial resistance

Many contributory factors, both scientific and economic, have limited the success of dual-acting hybrids where both partners are antibiotics. The success of cefiderocol highlights the potential of linking molecules that target bacteria directly and non-antibiotics. These strategies offer some exciting possibilities.